These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24632199)

  • 1. Lysophosphatidic acid receptor-5 negatively regulates cellular responses in mouse fibroblast 3T3 cells.
    Dong Y; Hirane M; Araki M; Fukushima N; Tsujiuchi T
    Biochem Biophys Res Commun; 2014 Apr; 446(2):585-9. PubMed ID: 24632199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of LPA1 on cell motile activities stimulated by hydrogen peroxide and 2,3-dimethoxy-1,4-naphthoquinone in fibroblast 3T3 cells.
    Hirane M; Araki M; Dong Y; Honoki K; Fukushima N; Tsujiuchi T
    Biochem Biophys Res Commun; 2013 Nov; 441(1):47-52. PubMed ID: 24134844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells.
    Araki M; Kitayoshi M; Dong Y; Hirane M; Ozaki S; Mori S; Fukushima N; Honoki K; Tsujiuchi T
    Growth Factors; 2014 Jun; 32(3-4):117-22. PubMed ID: 24798396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines.
    Dong Y; Hirane M; Araki M; Fukushima N; Honoki K; Tsujiuchi T
    Mol Cell Biochem; 2014 Aug; 393(1-2):17-22. PubMed ID: 24676544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid signaling via LPA
    Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
    Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid (LPA) signaling via LPA
    Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
    Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPA
    Minami K; Ueda N; Ishimoto K; Tsujiuchi T
    Exp Cell Res; 2020 Mar; 388(1):111813. PubMed ID: 31904382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bisphenol A and 4-nonylphenol on cellular responses through the different induction of LPA receptors in liver epithelial WB-F344 cells.
    Dong Y; Araki M; Hirane M; Tanabe E; Fukushima N; Tsujiuchi T
    J Recept Signal Transduct Res; 2014 Jun; 34(3):201-4. PubMed ID: 24460192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of LPA receptor-5 in the enhancement of cell motile activity by phorbol ester and anticancer drug treatments in melanoma A375 cells.
    Fukushima K; Takahashi K; Kurokawa A; Ishimoto K; Otagaki S; Minami K; Fukushima N; Honoki K; Tsujiuchi T
    Biochem Biophys Res Commun; 2018 Jan; 496(1):225-230. PubMed ID: 29309788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
    Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
    Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of activation factors of endothelia and fibroblasts via lysophosphatidic acid signaling in a mouse lung cancer LL/2 cell line.
    Tanabe E; Kitayoshi M; Hirane M; Araki M; Dong Y; Fukushima N; Tsujiuchi T
    J Recept Signal Transduct Res; 2013 Oct; 33(5):286-90. PubMed ID: 23909436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of lysophosphatidic acid receptor-3 suppresses cell migration activity of human sarcoma cells.
    Tanabe E; Kitayoshi M; Yoshikawa K; Shibata A; Honoki K; Fukushima N; Tsujiuchi T
    J Recept Signal Transduct Res; 2012 Dec; 32(6):328-34. PubMed ID: 23167620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse effects of LPA receptors on cell motile activities of cancer cells.
    Tsujiuchi T; Hirane M; Dong Y; Fukushima N
    J Recept Signal Transduct Res; 2014 Jun; 34(3):149-53. PubMed ID: 24460191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
    Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T
    Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different induction of LPA receptors by chemical liver carcinogens regulates cellular functions of liver epithelial WB-F344 cells.
    Hirane M; Ishii S; Tomimatsu A; Fukushima K; Takahashi K; Fukushima N; Honoki K; Tsujiuchi T
    Mol Carcinog; 2016 Nov; 55(11):1573-1583. PubMed ID: 26377854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2.
    Kato K; Fukui R; Okabe K; Tanabe E; Kitayoshi M; Fukushima N; Tsujiuchi T
    Biochem Biophys Res Commun; 2012 Jan; 417(2):790-3. PubMed ID: 22197817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid receptor-2 (LPA
    Takahashi K; Minami K; Otagaki S; Ishimoto K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2698-2703. PubMed ID: 30093116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na
    Jenkin KA; He P; Yun CC
    Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G433-G442. PubMed ID: 29792531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of oncogenic K-ras on cell migration stimulated by lysophosphatidic acid receptor-2 in pancreatic cancer cells.
    Yoshikawa K; Tanabe E; Shibata A; Inoue S; Kitayoshi M; Okimoto S; Fukushima N; Tsujiuchi T
    Exp Cell Res; 2013 Feb; 319(3):105-12. PubMed ID: 23041208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.
    Park SY; Jeong KJ; Panupinthu N; Yu S; Lee J; Han JW; Kim JM; Lee JS; Kang J; Park CG; Mills GB; Lee HY
    Oncogene; 2011 Mar; 30(11):1351-9. PubMed ID: 21102517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.